|
| The TGFαEGFRAkt signaling axis plays a role in enhancing proinflammatory chemokines in triplenegative breast cancer cells |
|
https://doi.org/10.18632/oncotarget.25389
Rosa Mistica C. Ignacio, Carla R. Gibbs, Eun-Sook Lee, and Deok-Soo Son
|
| 29286-29303 |
|
| Concomitant attenuation of HMGCoA reductase expression potentiates the cancer cell growthinhibitory effect of statins and expands their efficacy in tumor cells with epithelial characteristics |
|
https://doi.org/10.18632/oncotarget.25448
Takuro Ishikawa, Yoshinao Z. Hosaka, Colin Beckwitt, Alan Wells, Zoltán N. Oltvai, and Katsuhiko Warita
|
| 29304-29315 |
|
| Regionspecific alteration of histone modification by LSD1 inhibitor conjugated with pyrroleimidazole polyamide |
|
https://doi.org/10.18632/oncotarget.25451
Kokiladevi Alagarswamy, Ken-Ichi Shinohara, Shihori Takayanagi, Masaki Fukuyo, Atsushi Okabe, Bahityar Rahmutulla, Natsumi Yoda, Rui Qin, Naoki Shiga, Masahiro Sugiura, Hiroaki Sato, Kazuko Kita, Takayoshi Suzuki, Tetsuhiro Nemoto, and Atsushi Kaneda
|
| 29316-29335 |
|
| Frequent CLDN18ARHGAP fusion in highly metastatic diffusetype gastric cancer with relatively early onset |
|
https://doi.org/10.18632/oncotarget.25464
Atsushi Tanaka, Shumpei Ishikawa, Tetsuo Ushiku, Sho Yamazawa, Hiroto Katoh, Akimasa Hayashi, Akiko Kunita, and Masashi Fukayama
|
| 29336-29350 |
|
| Comparison of the prognostic impact and combination of preoperative inflammationbased and/or nutritional markers in patients with stage II gastric cancer |
|
https://doi.org/10.18632/oncotarget.25486
Takahiro Toyokawa, Kazuya Muguruma, Tatsuro Tamura, Katsunobu Sakurai, Ryosuke Amano, Naoshi Kubo, Hiroaki Tanaka, Masakazu Yashiro, Kosei Hirakawa, and Masaichi Ohira
|
| 29351-29364 |
|
| Neutral metalloaminopeptidases APN and MetAP2 as newly discovered anticancer molecular targets of actinomycin D and its simple analogs |
|
https://doi.org/10.18632/oncotarget.25532
Ewelina Węglarz-Tomczak, Michał Talma, Mirosław Giurg, Hans V. Westerhoff, Robert Janowski, and Artur Mucha
|
| 29365-29378 |
|
| Numb has distinct function in lung adenocarcinoma and squamous cell carcinoma |
|
https://doi.org/10.18632/oncotarget.25585
Hajime Kikuchi, Jun Sakakibara-Konishi, Megumi Furuta, Eiki Kikuchi, Junko Kikuchi, Satoshi Oizumi, Yasuhiro Hida, Kichizo Kaga, Ichiro Kinoshita, Hirotoshi Dosaka-Akita, and Masaharu Nishimura
|
| 29379-29391 |
|
| FcγRI expression on macrophages is required for antibodymediated tumor protection by cytomegalovirusbased vaccines |
|
https://doi.org/10.18632/oncotarget.25630
Hreinn Benonisson, Heng Sheng Sow, Cor Breukel, Jill W.C. Claassens, Conny Brouwers, Margot M. Linssen, Anke Redeker, Marieke F. Fransen, Thorbald van Hall, Ferry Ossendorp, Ramon Arens, and Sjef Verbeek
|
| 29392-29402 |
|
| Circulating tumor cells mirror bone metastatic phenotype in prostate cancer |
|
https://doi.org/10.18632/oncotarget.25634
Andreas Josefsson, Karin Larsson, Marianne Månsson, Jens Björkman, Eva Rohlova, Daniel Åhs, Helena Brisby, Jan-Erik Damber, and Karin Welén
|
| 29403-29413 |
|
| CRISPR/Cas9 nickase mediated targeting of urokinase receptor gene inhibits neuroblastoma cell proliferation |
|
https://doi.org/10.18632/oncotarget.25647
Karina D. Rysenkova, Ekaterina V. Semina, Maxim N. Karagyaur, Anna A. Shmakova, Daniyar T. Dyikanov, Petr A. Vasiluev, Yury P. Rubtsov, Kseniya A. Rubina, and Vsevolod A. Tkachuk
|
| 29414-29430 |
|
| Use of a novel camelidinspired human antibody demonstrates the importance of MMP14 to cancer stem cell function in the metastatic process |
|
https://doi.org/10.18632/oncotarget.25654
Kuan-Hui E. Chen, Chuan Chen, Tyler Lopez, Kelly C. Radecki, Karissa Bustamante, Mary Y. Lorenson, Xin Ge, and Ameae M. Walker
|
| 29431-29444 |
|
| MACROD2 expression predicts response to 5FUbased chemotherapy in stage III colon cancer |
|
https://doi.org/10.18632/oncotarget.25655
Evert van den Broek, Sjoerd H. den Uil, Veerle M.H. Coupé, Pien M. Delis-van Diemen, Anne S. Bolijn, Herman Bril, Hein B.A.C. Stockmann, Nicole C.T. van Grieken, Gerrit A. Meijer, and Remond J.A. Fijneman
|
| 29445-29452 |
|
| The sphingosine 1phosphate receptor 2 is shed in exosomes from breast cancer cells and is Nterminally processed to a short constitutively active form that promotes extracellular signal regulated kinase activation and DNA synthesis in fibroblasts |
|
https://doi.org/10.18632/oncotarget.25658
Ashref El Buri, David R. Adams, Douglas Smith, Rothwelle J. Tate, Margaret Mullin, Susan Pyne, and Nigel J. Pyne
|
| 29453-29467 |
|
| The calcium channel proteins ORAI3 and STIM1 mediate TGFβ induced Snai1 expression |
|
https://doi.org/10.18632/oncotarget.25672
Atrayee Bhattacharya, Janani Kumar, Kole Hermanson, Yuyang Sun, Humaira Qureshi, Danielle Perley, Adam Scheidegger, Brij B. Singh, and Archana Dhasarathy
|
| 29468-29483 |
|
| Bone mineral density and microarchitecture linkages with micro and macrovascular impairments at the hand in systemic sclerosis: an HRpQCT study |
|
https://doi.org/10.18632/oncotarget.25681
Lucie Atlan, Nada Ibrahim-Nasser, Antoine Valery, Carole Bazzi, François Rollin, Guido Bens, Mathilde Marot, Eric Estève, and Eric Lespessailles
|
| 29484-29494 |
|
| Tolllike receptor 4: a target for chemoprevention of hepatocellular carcinoma in obesity and steatohepatitis |
|
https://doi.org/10.18632/oncotarget.25685
Jennifer Nguyen, Jingjing Jiao, Kristin Smoot, Gordon P. Watt, Chen Zhao, Xingzhi Song, Heather L. Stevenson, Joseph B. McCormick, Susan P. Fisher-Hoch, Jianhua Zhang, P. Andrew Futreal, and Laura Beretta
|
| 29495-29507 |
|
| The relationship of CDK18 expression in breast cancer to clinicopathological parameters and therapeutic response |
|
https://doi.org/10.18632/oncotarget.25686
Giancarlo Barone, Arvind Arora, Anil Ganesh, Tarek Abdel-Fatah, Paul Moseley, Reem Ali, Stephen YT Chan, Constantinos Savva, Kristina Schiavone, Natasha Carmell, Katie N. Myers, Emad A. Rakha, Srinivasan Madhusudan, and Spencer J. Collis
|
| 29508-29524 |
|
| Clinical significance of repeat rebiopsy in detecting the EGFR T790M secondary mutation in patients with nonsmall cell lung cancer |
|
https://doi.org/10.18632/oncotarget.25705
Eiki Ichihara, Katsuyuki Hotta, Toshio Kubo, Tsukasa Higashionna, Kiichiro Ninomiya, Kadoaki Ohashi, Masahiro Tabata, Yoshinobu Maeda, and Katsuyuki Kiura
|
| 29525-29531 |
|
| Treatment of EGFR mutation–positive non–small cell lung cancer complicated by Trousseau syndrome with gefitinib followed by osimertinib: a case report |
|
https://doi.org/10.18632/oncotarget.25687
Yoshikane Nonagase, Masayuki Takeda, Kaoru Tanaka, Hidetoshi Hayashi, Tsutomu Iwasa, and Kazuhiko Nakagawa
|
| 29532-29535 |
|
| Correction: Beneficial bacteria inhibit cachexia |
|
https://doi.org/10.18632/oncotarget.25750
Bernard J. Varian, Sravya Gourishetti, Theofilos Poutahidis, Jessica R. Lakritz, Tatiana Levkovich, Caitlin Kwok, Konstantinos Teliousis, Yassin M. Ibrahim, Sheyla Mirabal, and Susan E. Erdman
|
| 29536-29536 |
|
| Correction: Circulating and tumorassociated caspase4: a novel diagnostic and prognostic biomarker for nonsmall cell lung cancer |
|
https://doi.org/10.18632/oncotarget.25751
Michela Terlizzi, Chiara Colarusso, Ilaria De Rosa, Nicolina De Rosa, Pasquale Somma, Carlo Curcio, Alessandro Sanduzzi, Pietro Micheli, Antonio Molino, Antonello Saccomanno, Rosario Salvi, Rita P. Aquino, Aldo Pinto, and Rosalinda Sorrentino
|
| 29537-29537 |
